Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts

Hormone and Metabolic Research

Volumn 40, Issue 12, 2008, Pages 869-874

  Giner, M ^a,c   Montoya, M J ^b   Vazquez M A ^b   Rios, M J ^b   Moruno, R ^b   Miranda, M J ^a   Perez Cano R ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c University Hospital   (Spain)

Author keywords

1,25dihydroxyvitamin D3; 17 estradiol; Human osteoblast culture; Osteoarthritis; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; COLLAGEN TYPE 1; ESTRADIOL; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; CASE REPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CHEMICAL MODIFICATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; OSTEOBLAST; OSTEOCLASTOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION;

ALKALINE PHOSPHATASE; CALCITRIOL; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN TYPE I; ESTRADIOL; HUMANS; OSTEOBLASTS; OSTEOCALCIN; RANK LIGAND; RNA, MESSENGER; VITAMINS;

EID: 58149136192     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082083     Document Type: Article

References (33)

1. Roux S, Orcel P. Bone loss. Factors that regulate osteoclast differentiation: an update. Arthritis Res 2000; 2: 451-456
2. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995; 332: 305-311
3. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001; 142: 5050-5055
4. Kaji H, Kanatani M, Sugimoto T, Chihara K. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures. Horm Metab Res 2005; 37: 589-592
5. Shirai Y, Yoshimura Y, Yawaka Y, Hasegawa T, Kikuiri T, Takeyama S, Matsumoto A, Oguchi H. Effect of extracellular calcium concentrations on osteoclast differentiation in vitro. Biochem Biophys Res Commun 1999; 265: 484-488
6. Deyama Y, Takeyama S, Koshikawa M, Shirai Y, Yoshimura Y, Nishikata M, Suzuki K, Matsumoto A. Osteoblast maturation suppressed osteoclastogenesis in coculture with bone marrow cells. Biochem Biophys Res Commun 2000; 274: 249-254
7. Thomas GP, Baker SUK, Eisman JA, Gardiner EM. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 2001; 170: 451-460
8. Stein GS, Lian JB. Molecular mechanisms mediating developmental and hormone-regulated expression of genes in osteoblasts: integrated relantionship of cell growth and differentiation. In: Noda M, ed. Cellular and molecular biology of bone. Tokyo: Academic Press 1993; 47-95
9. Siggelkow H, Rebenstorff K, Kurre W, Niedhart Ch, Engel I, Schilz H, Atkinson M, Hüfner M. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 1999; 75: 22-35
10. Ishida H, Bellows CG, Aubin JE, Heersche JN. Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells. Endocrinology 1993; 132: 61-66
11. Siggelkow H, Schulz H, Kaesler S, Benzler K, Atkinson MJ, Hüfner M. 1,25 dihydroxyvitamin-D3 attenuates the confluencedependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin. Calcif Tissue Int 1999; 64: 414-421
12. Bord S, Ireland DC, Beavan SR, Compston JE. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 2003; 32: 136-141
13. Pascher E, Perniok A, Becker A, Feldkamp J. Effect of 1alpha,25(OH)2-vitamin D3 on TNF alpha-mediated apoptosis of human primary osteoblast-like cells in vitro. Horm Metab Res 1999; 31: 653-656
14. Spreafico A, Frediani B, Capperucci C, Chellini F, Paffetti A, D'Ambrosio C, Bernardini G, Mini R, Collodel G, Scaloni A, Marcolongo R, Santucci A. A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics 2006; 6: 3520-3532
15. Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004; 25: 4105-4115
16. Martinez ME, del Campo MT, Medina S, Sanchez M, Sanchez-Cabezudo MJ, Esbrit P, Martinez P, Moreno I, Rodrigo A, Garces MV, Munuera L. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation. Calcif Tissue Int 1999; 64: 280-286
17. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991; 128: 1496-1504
18. Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 1987; 122: 49-60
19. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 2003; 177: 423-433
20. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 1999; 145: 527-538
21. Skoumal M, Kolarz G, Haberhauer G, Woloszczuk W, Hawa G, Klingler A. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstandin rheumatoid arthritis and osteoarthritis. Rheumatol Int 2005; 26: 63-69
22. Viereck V, Grundker C, Blaschke S, Siggelkow H, Emons G, Hofbauer LC. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 2002; 84: 725-735
23. Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 2000; 141: 4768-4776
24. Chen Q, Kaji H, Kanatani M, Sugimoto T, Chihara K. Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res 2004; 36: 674-678
25. Baldock PA, Thomas GP, Hodge JM, Baker SU, Dressel U, O'Loughlin PD, Nicholson GC, Briffa KH, Eisman JA, Gardiner EM. Vitamin d action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res 2006; 21: 1618-1626
26. 2+regulation. Horm Metab Res 2001; 33: 733-738
27. Chen FP, Lee N, Wang KC, Soong YK, Huang KE. Effect of estrogen and 1alpha,25(OH)2- vitamin D3 on the activity and growth of human primary osteoblast-like cells in vitro. Fertil Steril 2002; 77: 1038-1043
28. Bellido T, Girasole G, Passeri G, Yu XP, Mocharla H, Jilka RL, Notides A, Manolagas SC. Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology 1993; 133: 553-562
29. Vertino AM, Bula CM, Chen JR, Almeida M, Han L, Bellido T, Kousteni S, Norman AW, Manolagas SC. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol Chem 2005; 280: 14130-14137
30. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Löwik CW, Pols HA, Leeuwen JP van. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 1997; 138: 5067-5070
31. Bord S, Horner A, Beavan S, Compston J. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab 2001; 86: 2309-2314
32. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004; 25: 389-425
33. Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem 1994; 55: 273-286